supported publications or other works A Comparison of Laparoscopically Assisted and Open Colectomy for Colon Cancer Journal Articles A randomized phase 3 trial of thalidomide and prednisone as maintenance therapy after ASCT in patients with MM with a quality-of-life assessment: the National Cancer Institute of Canada Clinicals Trials Group Myeloma 10 Trial Journal Articles ABVD Alone versus Radiation-Based Therapy in Limited-Stage Hodgkin's Lymphoma Journal Articles Adjuvant chemotherapy and timing of tamoxifen in postmenopausal patients with endocrine-responsive, node-positive breast cancer: a phase 3, open-label, randomised controlled trial Journal Articles Autologous Transplantation as Consolidation for Aggressive Non-Hodgkin's Lymphoma Journal Articles Balancing Risks and Benefits of Therapy for Patients with Favorable-Risk Limited-Stage Hodgkin Lymphoma Journal Articles Cancer Antigen 15-3/Mucin 1 Levels in CCTG MA.32: A Breast Cancer Randomized Trial of Metformin vs Placebo Journal Articles Competing risks of death in women treated with adjuvant aromatase inhibitors for early breast cancer on NCIC CTG MA.27 Journal Articles Effect of Metformin Versus Placebo on New Primary Cancers in Canadian Cancer Trials Group MA.32: A Secondary Analysis of a Phase III Randomized Double-Blind Trial in Early Breast Cancer Journal Articles Effect of Metformin vs Placebo on Invasive Disease–Free Survival in Patients With Breast Cancer Journal Articles Effect of Metformin vs Placebo on and Metabolic Factors in NCIC CTG MA.32 Journal Articles Effect of metformin versus placebo on metabolic factors in the MA.32 randomized breast cancer trial Journal Articles Exemestane Versus Anastrozole in Postmenopausal Women With Early Breast Cancer: NCIC CTG MA.27—A Randomized Controlled Phase III Trial Journal Articles Extending Aromatase-Inhibitor Adjuvant Therapy to 10 Years Journal Articles Genetic Polymorphisms in the Long Noncoding RNA MIR2052HG Offer a Pharmacogenomic Basis for the Response of Breast Cancer Patients to Aromatase Inhibitor Therapy Journal Articles Genome-Wide Associations and Functional Genomic Studies of Musculoskeletal Adverse Events in Women Receiving Aromatase Inhibitors Journal Articles Impact of CYP19A1 and ESR1 variants on early-onset side effects during combined endocrine therapy in the TEXT trial Journal Articles Impact of baseline BMI and weight change in CCTG adjuvant breast cancer trials Journal Articles Implementation of Timeline Reforms Speeds Initiation of National Cancer Institute-Sponsored Trials Journal Articles Intermittent Androgen Suppression for Rising PSA Level after Radiotherapy Journal Articles Laparoscopic Colectomy for Cancer Is Not Inferior to Open Surgery Based on 5-Year Data From the COST Study Group Trial Journal Articles Lapatinib-Related Rash and Breast Cancer Outcome in the ALTTO Phase III Randomized Trial Journal Articles Metformin, placebo, and endocrine therapy discontinuation among participants in a randomized double-blind trial of metformin vs placebo in hormone receptor-positive early-stage breast cancer (CCTG MA32) Conferences Osteoporosis therapy and outcomes for postmenopausal patients with hormone receptor–positive breast cancer: NCIC CTG MA.27 Journal Articles Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial Journal Articles Prognostic associations of 25 hydroxy vitamin D in NCIC CTG MA.21, a phase III adjuvant randomized clinical trial of three chemotherapy regimens in high-risk breast cancer Journal Articles Prospective Validation of a 21-Gene Expression Assay in Breast Cancer Journal Articles Quality of Life From Canadian Cancer Trials Group MA.17R: A Randomized Trial of Extending Adjuvant Letrozole to 10 Years Journal Articles Regional Nodal Irradiation in Early-Stage Breast Cancer Journal Articles TLE3 is not a predictive biomarker for taxane sensitivity in the NCIC CTG MA.21 clinical trial Journal Articles Thalidomide‐prednisone maintenance following autologous stem cell transplant for Multiple Myeloma: effect on thrombin generation and procoagulant markers in NCIC CTG MY.10 Journal Articles